Four-Month High-Dose Rifampicin Regimens for Pulmonary Tuberculosis. (2023)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1056/evidoa2300054
PubMed Identifier: 38320155
Publication URI: http://europepmc.org/abstract/MED/38320155
Type: Journal Article/Review
Volume: 2
Parent Publication: NEJM evidence
Issue: 9
ISSN: 2766-5526